Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))

Moritz Reiterer; Mangala Rajan; Nicolás Gómez-Banoy; Jennifer D. Lau; Luis G. Gomez-Escobar; Lunkun Ma; Ankit Gilani; Sergio Alvarez-Mulett; Evan T. Sholle; Vasuretha Chandar; Yaron Bram; Katherine Hoffman; Priya Bhardwaj; Phoebe Piloco; Alfonso Rubio-Navarro; Skyler Uhl; Lucia Carrau; Sean Houhgton; David Redmond; Alpana P. Shukla; Parag Goyal; Kristy A. Brown; Benjamin R. tenOever; Laura C. Alonso; Robert E. Schwartz; Edward J. Schenck; Monika M. Safford; James C. Lo

doi:10.1016/j.cmet.2021.10.014

Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))

Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, Jennifer D. Lau, Luis G. Gomez-Escobar, Lunkun Ma, Ankit Gilani, Sergio Alvarez-Mulett, Evan T. Sholle, Vasuretha Chandar, Yaron Bram, Katherine Hoffman, Priya Bhardwaj, Phoebe Piloco, Alfonso Rubio-Navarro, Skyler Uhl, Lucia Carrau, Sean Houhgton, David Redmond, Alpana P. ShuklaParag Goyal, Kristy A. Brown, Benjamin R. tenOever, Laura C. Alonso, Robert E. Schwartz, Edward J. Schenck, Monika M. Safford, James C. Lo

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Abstract

(Cell Metabolism 33, 2174–2188.e1–e5, November 2, 2021) It was brought to the authors’ attention by readers that ARDS was not adequately defined. The STAR Methods have now been updated with specific clinical (ventilatory and oxygenation) parameters used to qualify for ARDS along with accompanying references.

Original language	English
Pages (from-to)	2484
Number of pages	1
Journal	Cell Metabolism
Volume	33
Issue number	12
DOIs	https://doi.org/10.1016/j.cmet.2021.10.014
State	Published - 7 Dec 2021

Access to Document

10.1016/j.cmet.2021.10.014

Fingerprint

Dive into the research topics of 'Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))'. Together they form a unique fingerprint.

Cite this

Reiterer, M., Rajan, M., Gómez-Banoy, N., Lau, J. D., Gomez-Escobar, L. G., Ma, L., Gilani, A., Alvarez-Mulett, S., Sholle, E. T., Chandar, V., Bram, Y., Hoffman, K., Bhardwaj, P., Piloco, P., Rubio-Navarro, A., Uhl, S., Carrau, L., Houhgton, S., Redmond, D., ... Lo, J. C. (2021). Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009)). Cell Metabolism, 33(12), 2484. https://doi.org/10.1016/j.cmet.2021.10.014

@article{b49962533b364cfaa90d30dc3d88a8da,

title = "Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))",

abstract = "(Cell Metabolism 33, 2174–2188.e1–e5, November 2, 2021) It was brought to the authors{\textquoteright} attention by readers that ARDS was not adequately defined. The STAR Methods have now been updated with specific clinical (ventilatory and oxygenation) parameters used to qualify for ARDS along with accompanying references.",

author = "Moritz Reiterer and Mangala Rajan and Nicol{\'a}s G{\'o}mez-Banoy and Lau, {Jennifer D.} and Gomez-Escobar, {Luis G.} and Lunkun Ma and Ankit Gilani and Sergio Alvarez-Mulett and Sholle, {Evan T.} and Vasuretha Chandar and Yaron Bram and Katherine Hoffman and Priya Bhardwaj and Phoebe Piloco and Alfonso Rubio-Navarro and Skyler Uhl and Lucia Carrau and Sean Houhgton and David Redmond and Shukla, {Alpana P.} and Parag Goyal and Brown, {Kristy A.} and tenOever, {Benjamin R.} and Alonso, {Laura C.} and Schwartz, {Robert E.} and Schenck, {Edward J.} and Safford, {Monika M.} and Lo, {James C.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = dec,

day = "7",

doi = "10.1016/j.cmet.2021.10.014",

language = "English",

volume = "33",

pages = "2484",

journal = "Cell Metabolism",

issn = "1550-4131",

publisher = "Cell Press",

number = "12",

}

Reiterer, M, Rajan, M, Gómez-Banoy, N, Lau, JD, Gomez-Escobar, LG, Ma, L, Gilani, A, Alvarez-Mulett, S, Sholle, ET, Chandar, V, Bram, Y, Hoffman, K, Bhardwaj, P, Piloco, P, Rubio-Navarro, A, Uhl, S, Carrau, L, Houhgton, S, Redmond, D, Shukla, AP, Goyal, P, Brown, KA, tenOever, BR, Alonso, LC, Schwartz, RE, Schenck, EJ, Safford, MM & Lo, JC 2021, 'Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))', Cell Metabolism, vol. 33, no. 12, pp. 2484. https://doi.org/10.1016/j.cmet.2021.10.014

Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009)). / Reiterer, Moritz; Rajan, Mangala; Gómez-Banoy, Nicolás et al.
In: Cell Metabolism, Vol. 33, No. 12, 07.12.2021, p. 2484.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009))

AU - Reiterer, Moritz

AU - Rajan, Mangala

AU - Gómez-Banoy, Nicolás

AU - Lau, Jennifer D.

AU - Gomez-Escobar, Luis G.

AU - Ma, Lunkun

AU - Gilani, Ankit

AU - Alvarez-Mulett, Sergio

AU - Sholle, Evan T.

AU - Chandar, Vasuretha

AU - Bram, Yaron

AU - Hoffman, Katherine

AU - Bhardwaj, Priya

AU - Piloco, Phoebe

AU - Rubio-Navarro, Alfonso

AU - Uhl, Skyler

AU - Carrau, Lucia

AU - Houhgton, Sean

AU - Redmond, David

AU - Shukla, Alpana P.

AU - Goyal, Parag

AU - Brown, Kristy A.

AU - tenOever, Benjamin R.

AU - Alonso, Laura C.

AU - Schwartz, Robert E.

AU - Schenck, Edward J.

AU - Safford, Monika M.

AU - Lo, James C.

PY - 2021/12/7

Y1 - 2021/12/7

N2 - (Cell Metabolism 33, 2174–2188.e1–e5, November 2, 2021) It was brought to the authors’ attention by readers that ARDS was not adequately defined. The STAR Methods have now been updated with specific clinical (ventilatory and oxygenation) parameters used to qualify for ARDS along with accompanying references.

AB - (Cell Metabolism 33, 2174–2188.e1–e5, November 2, 2021) It was brought to the authors’ attention by readers that ARDS was not adequately defined. The STAR Methods have now been updated with specific clinical (ventilatory and oxygenation) parameters used to qualify for ARDS along with accompanying references.

UR - http://www.scopus.com/inward/record.url?scp=85120503527&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2021.10.014

DO - 10.1016/j.cmet.2021.10.014

M3 - Comment/debate

C2 - 34879241

AN - SCOPUS:85120503527

SN - 1550-4131

VL - 33

SP - 2484

JO - Cell Metabolism

JF - Cell Metabolism

IS - 12

ER -

Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L et al. Erratum: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 (Cell Metabolism (2021) 33(11) (2174–2188.e5), (S1550413121004289), (10.1016/j.cmet.2021.09.009)). Cell Metabolism. 2021 Dec 7;33(12):2484. doi: 10.1016/j.cmet.2021.10.014